Automated Hospital Bed Market size will reach to USD 44.3 billion by 2029 : GreyViews

2022-12-08 11:50:06 By : Ms. Claire Cheng

Automated Hospital Bed Market Size By Type (Semi-Automatic and Fully Automatic), By Technology (Basic Automated and Smart Automated), By Treatment Type (Critical care, Long-Term Care, and Acute Care), By Usage (Intensive Care Delivery, Pressure Relief, General Purpose, Bariatric, Pediatric, Psychiatric Care, and Others), By End-User (Ambulatory Surgery Centers, Rehabilitation Centers, Hospitals, and Others) Regions, Segmentation, and forecast till 2029.

Pune India, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East and Africa. These are the key regions where the Automated Hospital Beds market is operating currently and is predicted to expand in the near future. The manufacturers and suppliers involved in the Automated Hospital Beds market is present across various countries in the above-mentioned regions.

Get Sample Copy of This Report @

The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the  type, technology, treatment type, usage, end-user, and region. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.

The significant players operating in the global Automated Hospital Beds market are Malvestio SpA, Paramount Bed Co Ltd, Linet spol. s.r.o, Stiegelmeyer GmbH & Co KG, Arjo Huntleigh, Gendron Inc., Hill-Rom Holdings, Invacare Corporation, Linetspol. Sr.o., Medline Industries, Inc., Paramount Bed Holdings Co. Ltd., and Stryker, among others. To achieve a substantial market share in the worldwide Automated Hospital Beds market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.

As patients need to rest, hospital beds are the most crucial piece of medical equipment. When patients are hospitalized, beds are an essential item they require, and they must be constructed to be as comfortable as possible while also shielding them from harm. Patients are kept comfortable during extended hospital stays thanks to automated hospital beds. Hospital beds with automated functionality are advantageous for patients with difficulty getting in and out of bed. Automated beds are used in surgical facilities, hospitals, and clinics alike. By using an automatic hospital bed, people unable to change positions or perform simple tasks on their own might regain their independence and confidence. An automatic hospital bed allows people who must spend a lot of time in bed to take charge of their motions and improve their comfort. Most electrical profiling beds allow for the automatic adjustment of bed height, simplifying and streamlining treatment. Even some beds can tilt. The function is known as Trendelenburg and is managed by a handset. Depending on the circumstance, an individual or a carer can use this remote control. The mattress platform's modular design can identify an autonomous hospital bed. This enables the user to change the device's height and tilt. Some beds' backrests can be raised to help the patient sit up. Some have a knee break or adjustable footrest to help elevate the legs. These beds offer support for the head, neck, back, knees, and hips. They are adaptable and clever. Depending on the user's specific needs, the bed may change to meet or even exceed those expectations regarding posture, comfort, and activity. An autonomous hospital bed has numerous advantages. Patients with chronic medical conditions and mobility problems can manage daily tasks more easily.

Enquiry Before Buying This Report @

Scope of Automated Hospital Beds Market Report

Base Year            

type, technology, treatment type, usage, end-user, and region.

North America, Europe, Asia-Pacific, South America and Middle-East and Africa

Malvestio SpA, Paramount Bed Co Ltd, Linet spol. s.r.o, Stiegelmeyer GmbH & Co KG, Arjo Huntleigh, Gendron Inc., Hill-Rom Holdings, Invacare Corporation, Linetspol. Sr.o., Medline Industries, Inc., Paramount Bed Holdings Co. Ltd., and Stryker, among others.

Semi-Automatic segment is expected to be the fastest growing segment in 2021.

The type segment is semi-automatic and fully automatic. The semi-automatic segment is expected to witness the highest growth rate during the forecast period. The growth can be attributed to its advantages, which include being less expensive than fully mechanical hospital beds, having manual height adjustment features, and having electronic head and foot sections. While in intensive care units, fully automatic hospital beds are typically preferred.

The smart automated segment is expected to be the fastest-growing segment in 2021.

The technology includes basic automated and smart automated. The smart automated segment is expected to witness the highest growth rate during the forecast period. Patient care, aid, and monitoring are just a few of the answers offered by smart, automated hospital beds. The smart Automated Hospital Beds market will experience tremendous demand due to the growing need from hospitals to replace their outdated equipment with new, technologically sophisticated technology.

The outdoor segment is expected to be the fastest-growing segment in 2021.

The application segment includes the segment includes outdoors, swimming, and others. The outdoor segment is expected to witness the highest growth rate during the forecast period. The skin of babies is sensitive which makes them prone to several rashes and infections when exposed to the outdoor environment. So, in most cases, it is advisable to use mineral sunscreen lotions when going outdoors to avoid sunburns, tanning, rashes, and allergies.

The general purpose segment is expected to be the fastest-growing segment in 2021.

The usage segment includes intensive care delivery, pressure relief, general purpose, bariatric, pediatric, psychiatric care, and others. The general purpose segment is expected to witness the highest growth rate during the forecast period. The general ward has more patients than the other wards, which explains why. In addition, a rising requirement for hospitals to treat people with minor injuries or illnesses is anticipated to fuel the market sector's future growth.

The hospital segment is expected to be the fastest-growing segment in 2021.

The end-user segment includes ambulatory surgery centers, rehabilitation centers, hospitals, and others. The hospital segment is expected to witness the highest growth rate during the forecast period. The market is expected to grow rapidly due to rising healthcare infrastructure spending and demand for smart hospital beds in medical institutions. Furthermore, hospitals have ample space and infrastructure to accommodate hospital beds which propels the market’s growth.

Regional Analysis                                                         

The regional analysis provides a detailed perception about the key regions and the countries. Some of the key countries analyzed for the Automated Hospital Beds include US, Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa and Saudi Arabia.

North America region witnessed a major share. Developed nations like the US, Canada, and Mexico are the main causes of the region's high share. Growing elderly populations, who are more susceptible to age-related illnesses, rising frequency and incidence of chronic diseases, and the region's high per capita health expenditures are all expected to boost the market in North America throughout the forecast period. The Asia Pacific is anticipated to experience significant growth during the predicted period. This can be ascribed to a growth in the number of people with chronic illnesses, as well as to new product availability and development in Asia, as well as to greater use of these devices in the region.

Germany's automated hospital bed market size was valued at USD 0.98 billion in 2021 and is expected to reach USD 1.59 billion by 2029, at a CAGR of 6.3% from 2022 to 2029. Because the pharmaceutical and medical industries are so prevalent, there is a growing demand for automated hospital beds. Additionally, market-friendly government policies are fueling expansion in this region.

China automated hospital beds’ market size was valued at USD 2.4 billion in 2021 and is expected to reach USD 4.2 billion by 2029, at a CAGR of 7.4% from 2022 to 2029.  Increased discretionary incomes, particularly in metropolitan areas, are driving the market. Furthermore, China has money available and is constantly searching the world for business opportunities. According to McKinsey, healthcare funds raised over $40 billion of capital in 2017, with over $10 billion going toward funding agreements. The trend slowed down in 2018, but Chinese funders are still backing US-based biotech in an increasingly prominent way (e.g., Grail, VielaBio) and are beginning to focus on Europe, where many biotechs could profit from access to new funding sources.

India's automated hospital bed market size was valued at USD 1.9 billion in 2021 and is expected to reach USD 3.2 billion by 2029, at a CAGR of 6.9% from 2022 to 2029. Because of the expanding population, rising consumer spending, and improvements in the healthcare industry, the region is expected to experience major growth in product demand. According to the Economic Survey of 2022, India's public healthcare spending increased from 1.8% of GDP in 2020–2021 to 2.1% in 2021–2022. These elements support the nation's demand for automated hospital beds. Covid-19 Impact

Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.

Furthermore, the growth of this market is mainly driven by the increasing prevalence of chronic diseases and the rising geriatric population.

Buy Now Full Report @

Rocky Shah GreyViews Pune India Phone: (+44) 162-237-1047 Email: Web: Follow Us: LinkedIn | Twitter

Single-use Assemblies Market Size By Product (Filtration Assemblies, Bottle Assemblies, Bag Assemblies, Tubing Assemblies, and Others), By End-Use (Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes, and CROs & CMOs), By Application (Filtration, Storage, Cell Culture & Mixing, Sampling, and Others), Regions, Segmentation, and Projection till 2029

Drug Discovery Outsourcing Market Size By Drug Type (Small and Large Molecules), By Therapeutic Area (Respiratory System, Oncology, Immunomodulation, and Others), By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, and Others), Regions, Segmentation, and Projection till 2029

Biochips Market Size By Type (Lab-on-chip, Cell Arrays, and DNA Chips), By End-use (Hospitals & Diagnostics Centers, Biotechnology And Pharmaceutical Companies, and Academic & Research Institutes), Regions, Segmentation, and Projection till 2029

Medical Radiation Protection Aprons Market Size By Type (Vest and Skirt Aprons, Front Protection Aprons, and Other Aprons), By Material (Light Lead Composite Aprons, Lead-Free Aprons, and Lead Aprons), By Application (Hospitals, Research Laboratories, and Clinics & Radiology Centers), Regions, Segmentation, and Projection till 2029

Tablet Coating Market Size By Coating Type (Film-coated, Sugar-coated, and Enteric-coated), By End-use (Pharmaceutical and Nutraceutical), By Polymer (Vinyl, Acrylic, and Cellulose), Regions, Segmentation, and Projection till 2029

Structural Health Monitoring Market Size By Application (Large Machines & Equipment, Bridges & Dams, Vessels & Platforms, Building & Stadiums, and Airframes & Wind Turbines), By Solution Type (Software & Services and Hardware), By Technology (Wired and Wireless), Regions, Segmentation, and Projection till 2029

Orthopedic Surgical Robots Market Size By Product Type (Robotic Accessories, Software and Services, and Robotic System), By End User (Hospital and Ambulatory Surgery Centers), Regions, Segmentation, and Projection till 2029

Behcet’s Disease Treatment Market Size By Type (Ocular-Behcet, Vasculo-Behcet, and Neuro-Behcet), By Route of Administration (Oral and Injectable), Regions, Segmentation, and Projection till 2029

Bleeding Disorders Treatment Market Size by Type (Hemophilia A, Hemophilia B, and Other), By Drug Class (Recombinant Coagulation Factor Concentrates, Plasma-derived Coagulation Factor Concentrates, Fibrin Sealants, and Other), Regions, Segmentation, and Projection till 2029

Bone Densitometer Devices Market Size By Technology (DEXA, QCT, Axial Bone Densitometry, Peripheral Bone Densitometry, and Others), By End-User (Clinics, Hospitals, and Others), Regions, Segmentation, and Projection till 2029

Shares of Mirati Therapeutics (NASDAQ: MRTX) slumped more than 28% on Wednesday. On Monday, the company released early phase 2 data on Adagrasib to treat non-small cell lung cancer (NSCLC), along with Keytruda, which is sold by Merck (NYSE: MRK). On Wednesday, Mirati presented the data from its Krystal 7 and Krystal 1 trials with Adagrasib, at the 2022 ESMO Immuno-Oncology Annual Congress.

Esperion Therapeutics Inc's (NASDAQ: ESPR) CLEAR Outcomes trial met its primary endpoint, demonstrating statistically significant risk reduction in MACE-4 in patients treated with 180 mg/day NEXLETOL (bempedoic acid) compared to placebo. The data demonstrate statistically significant and clinically meaningful results. The study included over 14,000 patients at over 1,200 sites in 32 countries. Bempedoic acid becomes the first ATP citrate lyase inhibitor and oral non-statin to meet the major adve

Prometheus Bio reported promising results from two inflammatory disease studies on Wednesday, and RXDX stock catapulted higher.

Mirati Therapeutics' (MRTX) preliminary data from the first-line NSCLC study showed that adagrasib plus Merck's Keytruda achieved an objective response rate of 49%.

GSK plc (NYSE: GSK) announced results from the PERLA phase 2 trial investigating Jemperli (dostarlimab) + chemotherapy versus Merck & Co Inc's (NYSE: MRK) Keytruda pembrolizumab + chemo as a first-line treatment for metastatic non-squamous non-small cell lung cancer (NSCLC). Dostarlimab plus chemotherapy achieved promising results for the primary endpoint of confirmed objective response rate (ORR) and the key secondary endpoint of median progression-free survival (mPFS). The ORR was 46% (n=56/12

Biogen (NASDAQ: BIIB) is a business that generates more than $10 billion in revenue each year, with its multiple sclerosis treatments bringing in the bulk of its sales. With the company's sales declining in recent years, Biogen needs a catalyst to turn things around and help inject some bullishness behind the business, and having an effective treatment for Alzheimer's could play a huge role in that objective. Next year could prove to be a pivotal one for Biogen as investors can finally get some much-needed answers about whether lecanemab, a promising Alzheimer's treatment, could be the game changer the healthcare company is hoping that it will be for the business.

Mirati said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed on questions about its market opportunity.

The new research published in The Journal of Allergy and Clinical Immunology uncovered how cold air impacts the nose and our immune systems.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid™ (COVID-19 Vaccine (Recombinant protein, Adjuvanted)) (NVX-CoV2373) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a primary series of

Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announced today significant results from the study of Onternabez combined with Favipiravir against ARDS (acute respiratory distress syndrome), Sepsis, and COVID-19 through PREPAiRE, an AI (Artificial Intelligence) powered platform which purposely integrates target identification, validation, lead discovery optimization, drug synthesis, and preclin

Consider, for instance, Editas Medicine (NASDAQ: EDIT) and BioXcel Therapeutics (NASDAQ: BTAI). Let's consider why Editas Medicine and BioXcel Therapeutics are worth keeping an eye on right now, and whether the potential rewards of investing in these companies outweigh the risks. The company is down by 61% this year, a terrible performance it partly owes to market-wide troubles.

Patients considering LASIK surgery should be warned that they may be left with double vision, dry eyes, difficulty driving at night and, in rare cases, persistent eye pain, according to draft guidance by the Food and Drug Administration. After surgery, patients might still need eyeglasses, the document warns. If put into effect, the agency’s warnings are likely to come as a surprise to many Americans, who view the procedure as safe and commonplace. Every year, more than half a million adults und

Biogen's (BIIB) tofersen, if approved, will be the first genetically-targeted treatment for SOD1-ALS in Europe.

The chicken, beans and vegetables are all cooked on the same pan, so this healthy dinner is easy to make and the cleanup is easy too. In this healthy salmon dinner, you'll get a dose of greens and green dressing!

There are currently higher-than-normal levels of RSV and the flu in the U.S. At the same time, the number of new COVID-19 infections is rising.

Eating ultra-processed foods for more than 20% of your caloric intake could impact your memory and executive function.

About 1 in 25 women in the United States will be diagnosed with the colorectal cancer in their lifetime and doctors urge regular screenings

New research finds yet another reason to eat almonds: gut health!

Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones

It feels like everyone is singing the praises of oatmeal lately. It can do wonders for your body, can help you live longer, and overall tastes delicious—especially when you make this peanut butter overnight oat recipe. But is oatmeal healthy? Are all of the side effects of eating oatmeal actually positive? Are there negative side effects we should know about, as well?We turned to a few registered dietitians and doctors to get the low-down on the good, the bad, and the ugly when it comes to oatme